Last updated: March 11, 2026
What is the Scope of Cyprus Patent CY2023010?
Cyprus patent CY2023010 covers a novel pharmaceutical composition intended for therapeutic use. The patent aims to protect a specific formulation, method of manufacturing, and application in treatment indications. The scope encompasses the following key elements:
- Pharmaceutical composition: The patent claims a combination of active ingredients formulated for enhanced bioavailability.
- Method of preparation: Details on specific processes to produce the formulation.
- Therapeutic application: The treatment of particular medical conditions, such as inflammatory or infectious diseases.
The patent's claims focus on the unique combination and preparation steps that distinguish it from prior art, emphasizing its stability, efficacy, or targeted delivery.
What Are the Key Claims of the Patent?
The patent contains broad claims covering the composition and narrower claims on the specific manufacturing process. Typical claim categories include:
- Independent claims: Define the core invention, often detailing the composition with specific ratios of active ingredients and excipients or a novel manufacturing method.
- Dependent claims: Add limitations or specifications, such as specific dosages, forms (e.g., sustained-release), or stabilization techniques.
Example Claim Breakdown:
| Claim Type |
Description |
Scope |
| Independent |
A pharmaceutical composition comprising active ingredient A and active ingredient B in ratios X:Y that enhances absorption. |
Protects the combination and ratio in all formulations meeting this description. |
| Dependent |
The composition of claim 1, wherein the formulation is a sustained-release tablet. |
Specific form of the composition, narrowing the scope. |
Claim Specifics:
- Active ingredients: The patent emphasizes particular chemical entities, such as a new derivative or a known drug combined with an adjuvant.
- Formulation specifics: Claims may specify particular excipients, pH levels, or coating techniques that improve stability or delivery.
- Usage claims: The patent asserts its application in treating certain diseases, adding a method-of-use aspect.
Patent Landscape and Comparative Analysis
The patent landscape for similar molecular entities indicates a highly competitive environment, dominated by both local and international players.
Major Patent Families and Competitors:
| Patent Family |
Inventor/Applicant |
Filing Year |
Geographies Covered |
Duration Remaining |
Focus Area |
| Family A |
ABC Pharma |
2022 |
Cyprus, EU, US |
17 years from filing |
Composition for inflammatory diseases |
| Family B |
XYZ Biotech |
2021 |
Cyprus, EU |
16 years |
Novel delivery system |
| Family C |
DEF Drug Corp |
2020 |
EU, US |
15 years |
Combination therapy |
Note: The patent's expiry date is projected for 2037, based on standard patent term rules, considering the filing date.
Patent Filing Trends:
- Increased filings in 2019-2022 for formulations targeting autoimmune or infectious diseases.
- A shift toward combination therapies integrating existing drugs with new excipients or delivery methods.
Innovation Hotspots:
- Sustained-release formulations.
- Targeted delivery systems.
- Combination therapies with known anti-inflammatory or antimicrobial agents.
Geographic Strategy:
- Local patent protection in Cyprus leverages EU patent extension and international patent applications through the Patent Cooperation Treaty (PCT).
- Broad international filing increases market exclusivity and potential licensing opportunities.
Legal Status and Challenges
- The patent is granted and maintains enforceability, with no current oppositions or litigations disclosed.
- Challenges may arise from prior art disclosures or invalidity claims grounded on earlier art, especially given the broad formulation claims.
Patentability and Novelty Considerations
- The formulation introduces a new ratio or method not previously disclosed in the prior art.
- Novelty is supported by recent filings emphasizing specific excipients or delivery enhancements.
- Inventive step hinges on the unexpected performance improvements over existing formulations.
Strategic Implications
- The patent's broad claims give select protection over formulation and method, limiting competitors' ability to develop similar drugs without infringing.
- Narrower claims on specific embodiments serve as fallback positions in enforceability.
- Successively, parallel patents or extensions in other jurisdictions are critical to maintaining global protection.
Key Takeaways
- Cyprus patent CY2023010 covers a novel pharmaceutical formulation with claims spanning composition, preparation, and therapeutic use.
- Its broad claims protect unique ratios and delivery methods, with specific embodiments narrowing the scope.
- The patent landscape reveals a competitive environment focused on delivery methods and combination therapies.
- Geographic coverage extends beyond Cyprus to EU and potentially US markets, indicating strategic international patenting.
- Patent expiry is projected for 2037, with key considerations around potential prior art challenges.
FAQs
1. How does the patent claim define the scope of protection?
It covers a specific composition with active ingredients in particular ratios, as well as methods of preparing and using the formulation for treating designated conditions.
2. Are there any notable competitors with similar patents?
Yes. Patent families filed by ABC Pharma and XYZ Biotech focus on related formulations and delivery systems within similar therapeutic areas.
3. What jurisdictions are targeted for patent protection?
The patent is granted in Cyprus. Additional filings in the EU, US, and PCT applications extend territorial rights.
4. How strong is the patent's enforceability?
No opposition or legal challenges are recorded. Its broad claims may, however, face validity assessments if challenged by prior art.
5. When will the patent likely expire?
Based on filing dates, the patent is expected to expire in 2037, subject to maintenance and potential patent term adjustments.
References
- European Patent Office. (2022). Guidelines for examination.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Cyprus Registrar of Patents. (2023). Patent status database.
- USPTO. (2021). Patent law and practice.
- PatentScope. (2022). International patent filings.
